Industry Focus
Healthcare: Eli Lilly’s Big Announcement, Plus GlaxoSmithKline Cozies Up to 23andMe
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:21:41
- Mais informações
Informações:
Sinopse
It’s big pharma week! First, we discuss Eli Lilly’s second quarter earnings and its decision to spin-off its animal health business. Then, we explain why GlaxoSmithKline became an investor in the DNA screening company, 23andMe.
